Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Hughes D - Pediatric sarcomas have diverse biology and distinct signaling pathways, making detailed preclinical evaluation of small molecule inhibitors essential to guiding the design of further clinical investigations.

Related Articles

Pediatric osteogenic sarcoma
Current Opinion in Pediatrics, 11/17/09    Relevance Score: 68%

Harmonizing adult and pediatric approaches to the treatment of soft-tissue sarcoma
Expert Review of Anticancer Therapy, 11/12/09    Relevance Score: 67%

FDG PET imaging of childhood sarcomas
Pediatric Blood & Cancer, 11/10/09    Relevance Score: 67%

Treatment of Relapsed/Refractory Pediatric Sarcomas With Gemcitabine and Docetaxel
Journal of Pediatric Hematology/Oncology, 11/06/09    Relevance Score: 67%

Alveolar soft-part sarcoma of the tongue in a 17-month-old
ENT Journal, 10/19/09    Relevance Score: 67%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address